Regulatory T cells participate in CD39-mediated protection from renal injury
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulatory T cells participate in CD39-mediated protection from renal injury
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 42, Issue 9, Pages 2441-2451
Publisher
Wiley
Online
2012-06-11
DOI
10.1002/eji.201242434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1 in Mouse Macrophage
- (2014) P. Pelegrin et al. JOURNAL OF IMMUNOLOGY
- Generation of anti-inflammatory adenosine byleukocytes is regulated by TGF-β
- (2011) Frederico S. Regateiro et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Subsets of human CD4+ regulatory T cells express the peripheral homing receptor CXCR3
- (2011) André Hoerning et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Extracellular ATP Is a Danger Signal Activating P2X7Receptor in Lung Inflammation and Fibrosis
- (2010) Nicolas Riteau et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- P2X7Receptor Signaling in the Pathogenesis of Smoke-Induced Lung Inflammation and Emphysema
- (2010) Monica Lucattelli et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A Potential Role for P2X7R in Allergic Airway Inflammation in Mice and Humans
- (2010) Tobias Müller et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Transgenic Overexpression of CD39 Protects Against Renal Ischemia-Reperfusion and Transplant Vascular Injury
- (2010) S. Crikis et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype
- (2010) K. M. Dwyer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Lack of the purinergic receptor P2X7results in resistance to contact hypersensitivity
- (2010) Felix C. Weber et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Extracellular NAD+shapes the Foxp3+regulatory T cell compartment through the ART2–P2X7 pathway
- (2010) Sandra Hubert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Deficiency or Inhibition of CD73 Protects in Mild Kidney Ischemia-Reperfusion Injury
- (2010) Siddharth V. Rajakumar et al. TRANSPLANTATION
- Isolated CD39 Expression on CD4+T Cells Denotes both Regulatory and Memory Populations
- (2009) Q. Zhou et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism
- (2009) Sabine Ring et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39
- (2009) Matthew C. Hyman et al. JOURNAL OF CLINICAL INVESTIGATION
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
- (2009) J. M. Fletcher et al. JOURNAL OF IMMUNOLOGY
- P2X7 Deficiency Attenuates Renal Injury in Experimental Glomerulonephritis
- (2009) S. R.J. Taylor et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury
- (2009) W. Peng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unresolved issues and controversies in purinergic signalling
- (2008) Geoffrey Burnstock JOURNAL OF PHYSIOLOGY-LONDON
- The Impact of Purinergic Signaling on Renal Ischemia-Reperfusion Injury
- (2008) Bo Lu et al. TRANSPLANTATION
- Foxp3+CD4+ T cell-mediated immunosuppression involves extracellular nucleotide catabolism
- (2008) Margaret S. Bynoe et al. TRENDS IN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now